Literature DB >> 24846266

Managing a biobank network.

Manuel M Morente1, Laura Cereceda, Francisco Luna-Crespo, Maria J Artiga.   

Abstract

Today's biomedical research of excellence is mainly seen as a global phenomenon around the study of large series of samples organized with well-defined and detailed criteria regarding the identification of patients, with the specific information required in each case. This justifies the growing interest in developing cooperative networks of biobanks to minimize biases arising from heterogeneity in the quality of biological samples by means of protocols for procedures, development of common quality assurance policies, and promotion of collaborative environments. This article focuses on some basic aspects of biobank networking, including design and management. It does not try to be an exhaustive analysis but a preliminary approach to the topic, based on the author's expertise in biobank networking in Spain.

Entities:  

Year:  2011        PMID: 24846266     DOI: 10.1089/bio.2011.0005

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  2 in total

1.  Qualitative study on custodianship of human biological material and data stored in biobanks.

Authors:  Michiel Verlinden; Herman Nys; Nadine Ectors; Isabelle Huys
Journal:  BMC Med Ethics       Date:  2016-03-01       Impact factor: 2.652

2.  Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.

Authors:  José Antonio López-Guerrero; Marta Mendiola; José Alejandro Pérez-Fidalgo; Ignacio Romero; Ana Torres; Delia Recalde; Elena Molina; César Gómez-Raposo; Ana M Levin; Ana Herrero; Jesús Alarcón; Carmen Esteban; Gloria Marquina; María Jesús Rubio; Eva Guerra; Luisa Sánchez-Lorenzo; Fernando Gálvez-Montosa; Ana de Juan; Cristina Churruca; Alejandro Gallego; Antonio González-Martín
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.